At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53,902 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Postlicensure Observational Safety Study of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Administered in Routine Use to Infants and Toddlers
In Brief
An observational study evaluating No Intervention for Pneumococcal Disease. Completed, enrolled 53,902 participants across 1 site.
Detailed Summary
The purpose of the study is to expand the understanding of the safety profile of 13vPnC in routine use following licensure and introduction of the vaccine.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumococcal Disease
CountriesUnited States
CollaboratorsKaiser Permanente
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2010
Enrollment StartJun 2010
Primary CompletionJun 2013
TodayJul 2026
First PostedMay 21, 2010
Enrollment StartJun 1, 2010
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 16.1 years ago
Interventions
No Interventionother
No Intervention